WESTPORT, Conn., March 9, 2017 /PRNewswire/ -- Q30 Innovations today announced it has won the 2017 Alpha Award for
The Q-Collar, which employs the body's own physiology to create a bubble-wrap effect for the brain, is being developed by Q30 Innovations for athletes, soldiers and industrial workers. It gently compresses the jugular vein to mildly increase blood volume in the cranium, creating a "tighter fit" of the brain inside the skull. This action is proposed to reduce "slosh" – i.e., the twisting and slamming of the brain against the skull's interior walls, which is one cause of mild traumatic brain injury (mTBI), or concussion.
For more than five years, Q30 has been focused on the development of the Q-Collar to reduce the risk and severity of brain injury suffered by athletes and military personnel who are at risk.
"The Alpha Award for Best Analytics Innovation/Technology is a tremendous honor that goes to the heart of how the Q-Collar was conceived – a blend of eureka moments and painstaking R&D," said Tom Hoey, co-CEO of Q30 Innovations. "We won't stop until every athlete has the opportunity to reduce their chances of mild traumatic brain injury in sports and beyond."
The Q-Collar was the centerpiece of two scientific studies published in 2016 that showed early evidence it may reduce brain injuries in high-school football and hockey players. The studies, performed by Cincinnati Children's Hospital Medical Center, constituted the first evidence of the effectiveness of the collar on human subjects.
The 11th annual SSAC was hosted by the MIT Sloan School of Management at the Hynes Convention Center in Boston, Mass., attracting a number of leaders in the sports technology industry as well as major sponsors including Rebook, SAP, Intel, and lead sponsor ESPN.
About Q30 Innovations A global company based in Westport, Conn., Q30 Innovations, LLC, uses independent scientific research and innovative thinking to design products intended to reduce traumatic brain injury in athletes, soldiers, and industry workers. Products using Q30's technology have not yet received regulatory approval and are not available for purchase in the United States.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/q30-innovations-wins-mit-award-for-product-innovation-300421233.html
SOURCE Q30 Innovations
Subscribe to our Free Newsletters!
Acute coronary syndrome (ACS) is a sudden, acute life-threatening condition caused by a dramatic ...
Sclerotherapy is a procedure used to treat spider veins, varicose veins and hemorrhoids by directly ...
HELLP syndrome is a rare but serious complication that affects pregnant women. If detected on time, ...View All